TLR2 regulation of NF-κB and NLRP3-driven pyroptosis in Alzheimer's disease

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Upregulation of toll-like receptor 2 (TLR2) excessively activates pro-inflammatory microglia via amyloid-beta (Aβ) peptides in Alzheimer's disease (AD).
• The precise role of TLR2 in regulating neuronal pyroptosis through the NF-κB/NLRP3 pathway in AD remains largely unelucidated.

Purpose of the Study:

• To investigate whether TLR2 regulates neuronal pyroptosis via the NF-κB/NLRP3 pathway in Alzheimer's disease.
• To explore TLR2 as a potential therapeutic target for AD.

Main Methods:

• Assessed TLR2 expression in clinical peripheral blood samples and SH-SY5Y cells.
• Simulated AD pathology using Aβ_1-42 stimulation.
• Conducted TLR2 knockdown, NF-κB overexpression, and NLRP3 activation experiments in vitro.
• Administered sh-TLR2 treatment to APP/PS1 mice for in vivo validation.

Main Results:

• High TLR2 expression activated the NF-κB/NLRP3 pathway and promoted pyroptosis.
• TLR2 silencing suppressed Aβ_1-42-induced pyroptosis in SH-SY5Y cells by inhibiting this pathway.
• NF-κB overexpression or NLRP3 activation partially reversed the protective effects of TLR2 silencing, confirming pathway involvement.
• In vivo experiments in AD mice corroborated the role of TLR2 knockdown.

Conclusions:

• TLR2 significantly drives neuronal pyroptosis through the NF-κB/NLRP3 pathway in Alzheimer's disease.
• Targeting TLR2 presents a novel therapeutic avenue for AD, complementing existing microglia-focused strategies.
• Further validation in advanced models is recommended to enhance clinical translational potential.